サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：短腸症候群市場- 世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年
市場調査レポート
商品コード
1334442

短腸症候群市場- 世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年

Short Bowel Syndrome Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Distribution Channel ; By Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 400 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
短腸症候群市場- 世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年
出版日: 2023年08月02日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

短腸症候群の世界市場規模は2029年までに20億米ドルを超える勢い

世界の短腸症候群（SBS）市場は、非経口栄養の高コストと短腸症候群の有病率の増加によるSBS治療薬の需要増加で活況を呈しています。

戦略コンサルティングと市場調査の大手企業であるBlueWeave Consulting社は、最近の調査で、2022年の短腸症候群の世界市場規模を8億2,829万米ドルと推定しました。BlueWeave社は、2023年から2029年までの予測期間において、世界の短腸症候群市場規模は14.05%の大幅なCAGRで拡大し、2029年には20億5,324万米ドルに達すると予測しています。世界の短腸症候群市場の主な成長促進要因としては、消化器疾患の有病率の増加、医療技術の進歩、医療従事者や患者の意識の高まりなどが挙げられます。短腸症候群の発生率は世界的に上昇しており、その主な原因は、消化管手術、先天異常、炎症性腸疾患、小腸の大部分を切除または機能不全に導くその他の疾患などの要因です。このような有病率の増加は、効果的な治療オプションに対する需要を生み出しています。医療技術の進歩は、短腸症候群に対する革新的な治療法の開発において重要な役割を果たしています。これらの進歩には、非経口栄養ソリューション、腸管移植術、腸管リハビリテーション・プログラムなどが含まれ、患者の転帰を改善し、市場の成長に寄与しています。また、製薬会社や研究機関は、短腸症候群の新たな治療法を発見・開発するための研究開発に積極的に投資しています。こうした取り組みは、患者のQOLを向上させ、この分野における既存のアンメット・メディカル・ニーズに対応することを目的としています。その結果、これらの要因が予測期間を通じて世界の短腸症候群市場の拡大を促進すると予想されます。しかし、SBS治療の高額な費用とSBSの長期的な合併症が、分析期間中の市場全体の成長を抑制すると予測されています。

本レポートの詳細な分析により、世界の短腸症候群市場の成長可能性、今後の動向、統計に関する情報を提供します。また、総市場規模の予測を促進する要因も取り上げています。当レポートは、世界の短腸症候群市場における最近の技術動向や、意思決定者が健全な戦略的意思決定を行うための業界洞察を提供することをお約束します。さらに、市場の成長促進要因・課題・競争力についても分析しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の短腸症候群市場に関する洞察

  • 業界のバリューチェーン分析
  • DROC分析
    • 成長促進要因
      • 短腸症候群の有病率の増加
      • 非経口栄養費の高騰によりSBS医薬品の需要が増大
    • 抑制要因
      • 高額なSBS治療費
      • SBSの長期合併症
    • 機会
      • 新しいSBS薬と治療法の開発
      • 他社とのパートナーシップおよびコラボレーション
    • 課題
      • 厳しい規制要件
      • ジェネリック医薬品との競合
  • 技術の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界の短腸症候群市場概要

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
      • GLP-2
      • 成長ホルモン
      • グルタミン
      • その他
    • 流通チャネル別
      • 病院薬局
      • 小売薬局
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋（APAC）
      • ラテンアメリカ（LATAM）
      • 中東およびアフリカ（MEA）

第5章 北米短腸症候群市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 流通チャネル別
    • 国別
      • 米国
      • カナダ

第6章 欧州短腸症候群市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 流通チャネル別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • ベルギー
      • ロシア
      • その他欧州

第7章 アジア太平洋地域の短腸症候群市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 流通チャネル別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリアとニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • ベトナム
      • APACのその他の地域

第8章 ラテンアメリカ短腸症候群市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 流通チャネル別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • 中南米のその他の地域

第9章 中東およびアフリカの短腸症候群市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 流通チャネル別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • MEAのその他の地域

第10章 競合情勢

  • 主要企業とその製品のリスト
  • 世界の短腸症候群市場シェア分析、2022年
  • 動作パラメータによる競合ベンチマーキング
  • 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 世界の短腸症候群市場に対するCOVID-19の影響

第12章 企業プロファイル（会社概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先住所、戦略的展望、 SWOT分析）

  • Takeda
  • Emmaus Life Sciences
  • Nutricia（Danone）
  • Merck KGaA
  • GlyPharma Therapeutics
  • Zealand Pharma
  • Sancilio Pharmaceuticals
  • Naia Pharmaceuticals
  • Ardelyx
  • Adocia
  • Aralez Pharmaceuticals
  • Shield Therapeutics
  • OxThera
  • Rhythm Pharmaceuticals
  • Pivot Pharmaceuticals
  • Other Prominent Players

第13章 主要な戦略的推奨事項

第14章 調査手法

  • 定性的調査
    • 一次および2次調査
  • 定量的調査
  • 市場内訳とデータの三角測量
    • 2次調査
    • 1次調査
  • 1次調査回答者の地域別内訳
  • 前提と制限

※非上場企業の財務情報も随時提供可能です。

目次
Product Code: BWC23628

Global Short Bowel Syndrome Market Size Booming to Cross USD 2 Billion by 2029.

Global short bowel syndrome (SBS) market is flourishing because of an increasing demand for SBS drugs due to the high cost of parenteral nutrition and the growing prevalence of short bowel syndrome.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global short bowel syndrome market size at USD 828.29 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global short bowel syndrome market size to expand at a significant CAGR of 14.05% reaching a value of USD 2,053.24 million by 2029. Major growth drivers for the global short bowel syndrome market include an increasing prevalence of gastrointestinal disorders, advancements in medical technology, and growing awareness among healthcare professionals and patients. The incidence of short bowel syndrome is rising globally, primarily due to factors such as gastrointestinal surgeries, congenital anomalies, inflammatory bowel diseases, and other conditions leading to the removal or dysfunction of a significant portion of the small intestine. This growing prevalence has created a demand for effective treatment options. Advancements in medical technology have played a crucial role in the development of innovative therapies for short bowel syndrome. These advancements encompass parenteral nutrition solutions, intestinal transplantation procedures, and intestinal rehabilitation programs, which have improved patient outcomes and are contributing to market growth. Also, pharmaceutical companies and research organizations are actively investing in research and development efforts to discover and develop new treatment options for short bowel syndrome. These initiatives aim to enhance patients' quality of life and address the existing unmet medical needs in this field. As a result, these factors are expected to drive the expansion of the global short bowel syndrome market throughout the forecast period. However, the high cost of SBS treatment and long-term complications of SBS are anticipated to restrain the overall market growth during the period in analysis.

Global Short Bowel Syndrome Market - Overview:

The global Short Bowel Syndrome (SBS) market encompasses the diagnosis, treatment, and management of a condition characterized by the loss or dysfunction of a significant portion of the small intestine. It involves pharmaceutical companies, medical device manufacturers, research organizations, and healthcare providers. Key products and services include pharmacological therapies, parenteral nutrition solutions, medical devices, surgical interventions, rehabilitation programs, and support services. The market is driven by factors such as the rising prevalence of gastrointestinal disorders, advancements in medical technology, research and development investments, and the need for effective SBS management. Market players strive to develop innovative therapies and interventions to improve patient outcomes and quality of life.

Impact of COVID-19 on Global Short Bowel Syndrome Market:

COVID-19 pandemic adversely affected the global short bowel syndrome market. The healthcare systems' focus on managing COVID-19 cases, disruptions in the supply chain, and restrictions on non-essential healthcare services have affected the diagnosis, treatment, and management of SBS. Clinical trials for new therapies and medical device development have been delayed or halted, impacting research and development activities. Also, the economic impact of the pandemic has affected healthcare budgets, potentially limiting patients' access to expensive SBS treatments. However, as the situation improved, the market gradually recovered, supported by increased healthcare investments and a resurgence in research and development efforts.

Global Short Bowel Syndrome Market - By Type:

By type, the global short bowel syndrome market is divided into GLP-2, Growth Hormone, and Glutamine segments. The GLP-2 (glucagon-like peptide-2) segment holds the highest share in the global Short Bowel Syndrome (SBS) market due to its effectiveness in managing the condition. GLP-2 is a hormone that plays a crucial role in promoting intestinal growth, enhancing nutrient absorption, and reducing fluid loss. It has shown promising results in clinical trials and is approved for the treatment of SBS in several regions. GLP-2 therapies, such as Teduglutide, have demonstrated the ability to reduce dependence on parenteral nutrition and improve intestinal function. The proven efficacy of GLP-2 treatments has led to their widespread adoption, contributing to the segment's dominant market share in the global SBS market.

Competitive Landscape:

Major players operating in the global short bowel syndrome market include: Takeda, Emmaus Life Sciences, Nutricia (Danone), Merck KGaA, GlyPharma Therapeutics, Zealand Pharma, Sancilio Pharmaceuticals, Naia Pharmaceuticals, Ardelyx, Adocia, Aralez Pharmaceuticals, Shield Therapeutics, OxThera, Rhythm Pharmaceuticals, and Pivot Pharmaceuticals. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Short Bowel Syndrome Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Short Bowel Syndrome Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Short Bowel Syndrome Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing prevalence of short bowel syndrome
      • 3.2.1.2. Growing demand for SBS drugs due to the high cost of parenteral nutrition
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of SBS treatment
      • 3.2.2.2. Long-term complications of SBS
    • 3.2.3. Opportunities
      • 3.2.3.1. Development of new SBS drugs and therapies
      • 3.2.3.2. Partnerships and collaborations with other companies
    • 3.2.4. Challenges
      • 3.2.4.1. Stringent regulatory requirements
      • 3.2.4.2. Competition from generic drugs
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Short Bowel Syndrome Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Type
      • 4.2.1.1. GLP-2
      • 4.2.1.2. Growth Hormone
      • 4.2.1.3. Glutamine
      • 4.2.1.4. Others
    • 4.2.2. By Distribution Channel
      • 4.2.2.1. Hospital Pharmacies
      • 4.2.2.2. Retail Pharmacies
      • 4.2.2.3. Others
    • 4.2.3. By Region
      • 4.2.3.1. North America
      • 4.2.3.2. Europe
      • 4.2.3.3. Asia Pacific (APAC)
      • 4.2.3.4. Latin America (LATAM)
      • 4.2.3.5. Middle East and Africa (MEA)

5. North America Short Bowel Syndrome Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Distribution Channel
    • 5.2.3. By Country
      • 5.2.3.1. United States
      • 5.2.3.1.1. By Type
      • 5.2.3.1.2. By Distribution Channel
      • 5.2.3.2. Canada
      • 5.2.3.2.1. By Type
      • 5.2.3.2.2. By Distribution Channel

6. Europe Short Bowel Syndrome Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
      • 6.2.3.1. Germany
      • 6.2.3.1.1. By Type
      • 6.2.3.1.2. By Distribution Channel
      • 6.2.3.2. United Kingdom
      • 6.2.3.2.1. By Type
      • 6.2.3.2.2. By Distribution Channel
      • 6.2.3.3. Italy
      • 6.2.3.3.1. By Type
      • 6.2.3.3.2. By Distribution Channel
      • 6.2.3.4. France
      • 6.2.3.4.1. By Type
      • 6.2.3.4.2. By Distribution Channel
      • 6.2.3.5. Spain
      • 6.2.3.5.1. By Type
      • 6.2.3.5.2. By Distribution Channel
      • 6.2.3.6. Belgium
      • 6.2.3.6.1. By Type
      • 6.2.3.6.2. By Distribution Channel
      • 6.2.3.7. Russia
      • 6.2.3.7.1. By Type
      • 6.2.3.7.2. By Distribution Channel
      • 6.2.3.8. Rest of Europe
      • 6.2.3.8.1. By Type
      • 6.2.3.8.2. By Distribution Channel

7. Asia Pacific Short Bowel Syndrome Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
      • 7.2.3.1. China
      • 7.2.3.1.1. By Type
      • 7.2.3.1.2. By Distribution Channel
      • 7.2.3.2. India
      • 7.2.3.2.1. By Type
      • 7.2.3.2.2. By Distribution Channel
      • 7.2.3.3. Japan
      • 7.2.3.3.1. By Type
      • 7.2.3.3.2. By Distribution Channel
      • 7.2.3.4. South Korea
      • 7.2.3.4.1. By Type
      • 7.2.3.4.2. By Distribution Channel
      • 7.2.3.5. Australia & New Zealand
      • 7.2.3.5.1. By Type
      • 7.2.3.5.2. By Distribution Channel
      • 7.2.3.6. Indonesia
      • 7.2.3.6.1. By Type
      • 7.2.3.6.2. By Distribution Channel
      • 7.2.3.7. Malaysia
      • 7.2.3.7.1. By Type
      • 7.2.3.7.2. By Distribution Channel
      • 7.2.3.8. Singapore
      • 7.2.3.8.1. By Type
      • 7.2.3.8.2. By Distribution Channel
      • 7.2.3.9. Vietnam
      • 7.2.3.9.1. By Type
      • 7.2.3.9.2. By Distribution Channel
      • 7.2.3.10. Rest of APAC
      • 7.2.3.10.1. By Type
      • 7.2.3.10.2. By Distribution Channel

8. Latin America Short Bowel Syndrome Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
      • 8.2.3.1. Brazil
      • 8.2.3.1.1. By Type
      • 8.2.3.1.2. By Distribution Channel
      • 8.2.3.2. Mexico
      • 8.2.3.2.1. By Type
      • 8.2.3.2.2. By Distribution Channel
      • 8.2.3.3. Argentina
      • 8.2.3.3.1. By Type
      • 8.2.3.3.2. By Distribution Channel
      • 8.2.3.4. Peru
      • 8.2.3.4.1. By Type
      • 8.2.3.4.2. By Distribution Channel
      • 8.2.3.5. Rest of LATAM
      • 8.2.3.5.1. By Type
      • 8.2.3.5.2. By Distribution Channel

9. Middle East & Africa Short Bowel Syndrome Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
      • 9.2.3.1. Saudi Arabia
      • 9.2.3.1.1. By Type
      • 9.2.3.1.2. By Distribution Channel
      • 9.2.3.2. UAE
      • 9.2.3.2.1. By Type
      • 9.2.3.2.2. By Distribution Channel
      • 9.2.3.3. Qatar
      • 9.2.3.3.1. By Type
      • 9.2.3.3.2. By Distribution Channel
      • 9.2.3.4. Kuwait
      • 9.2.3.4.1. By Type
      • 9.2.3.4.2. By Distribution Channel
      • 9.2.3.5. South Africa
      • 9.2.3.5.1. By Type
      • 9.2.3.5.2. By Distribution Channel
      • 9.2.3.6. Nigeria
      • 9.2.3.6.1. By Type
      • 9.2.3.6.2. By Distribution Channel
      • 9.2.3.7. Algeria
      • 9.2.3.7.1. By Type
      • 9.2.3.7.2. By Distribution Channel
      • 9.2.3.8. Rest of MEA
      • 9.2.3.8.1. By Type
      • 9.2.3.8.2. By Distribution Channel

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Short Bowel Syndrome Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Short Bowel Syndrome Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Takeda
  • 12.2. Emmaus Life Sciences
  • 12.3. Nutricia (Danone)
  • 12.4. Merck KGaA
  • 12.5. GlyPharma Therapeutics
  • 12.6. Zealand Pharma
  • 12.7. Sancilio Pharmaceuticals
  • 12.8. Naia Pharmaceuticals
  • 12.9. Ardelyx
  • 12.10. Adocia
  • 12.11. Aralez Pharmaceuticals
  • 12.12. Shield Therapeutics
  • 12.13. OxThera
  • 12.14. Rhythm Pharmaceuticals
  • 12.15. Pivot Pharmaceuticals
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

Figures

  • Figure 1 Global Short Bowel Syndrome Market Segmentation
  • Figure 2 Global Short Bowel Syndrome Market Value Chain Analysis
  • Figure 3 Company Market Share Analysis, 2022
  • Figure 4 Global Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 5 Global Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 6 Global Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 7 Global Short Bowel Syndrome Market Share, By Region, By Value, 2019-2029
  • Figure 8 North America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 9 North America Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 10 North America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 11 North America Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
  • Figure 12 United States Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 13 United States Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 14 United States Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 15 Canada Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 16 Canada Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 17 Canada Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 18 Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 19 Europe Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 20 Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 21 Europe Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
  • Figure 22 Germany Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 23 Germany Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 24 Germany Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 25 United Kingdom Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 26 United Kingdom Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 27 United Kingdom Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 28 Italy Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 29 Italy Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 30 Italy Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 31 France Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 32 France Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 33 France Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 34 Spain Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 35 Spain Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 36 Spain Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 37 Belgium Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 38 Belgium Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 39 Belgium Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 40 Rest of Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 41 Rest of Europe Short Bowel Syndrome Market Share, By Technology, By Value, 2019-2029
  • Figure 42 Rest of Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 43 The Asia-Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 44 The Asia-Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 45 The Asia-Pacific Short Bowel Syndrome Market Share, By Deployment, By Value, 2019-2029
  • Figure 46 The Asia-Pacific Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
  • Figure 47 China Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 48 China Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 49 China Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 50 India Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 51 India Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 52 India Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 53 Japan Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 54 Japan Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 55 Japan Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 56 South Korea Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 57 South Korea Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 58 South Korea Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 59 Australia & New Zealand Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 60 Australia & New Zealand Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 61 Australia & New Zealand Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 62 Indonesia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 63 Indonesia Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 64 Indonesia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 65 Malaysia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 66 Malaysia Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 67 Malaysia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 68 Singapore Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 69 Singapore Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 70 Singapore Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 71 Vietnam Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 72 Vietnam Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 73 Vietnam Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 74 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 75 Rest of Asia Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 76 Rest of Asia Pacific Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 77 Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 78 Latin America Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 79 Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 80 Latin America Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
  • Figure 81 Brazil Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 82 Brazil Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 83 Brazil Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 84 Mexico Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 85 Mexico Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 86 Mexico Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 87 Argentina Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 88 Argentina Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 89 Argentina Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 90 Peru Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 91 Peru Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 92 Peru Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 93 Rest of Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 94 Rest of Latin America Short Bowel Syndrome Market Share, By Type By Value, 2019-2029
  • Figure 95 Rest of Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 96 The Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 97 The Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 98 The Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 99 The Middle East & Africa Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
  • Figure 100 Saudi Arabia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 101 Saudi Arabia Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 102 Saudi Arabia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 103 UAE Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 104 UAE Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 105 UAE Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 106 Qatar Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 107 Qatar Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 108 Qatar Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 109 Kuwait Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 110 Kuwait Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 111 Kuwait Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 112 Iran Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 113 Iran Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 114 Iran Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 115 South Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 116 South Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 117 South Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 118 Nigeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 119 Nigeria Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 120 Nigeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 121 Kenya Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 122 Kenya Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 123 Kenya Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 124 Egypt Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 125 Egypt Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 126 Egypt Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 127 Morocco Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 128 Morocco Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 129 Morocco Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 130 Algeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 131 Algeria Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 132 Algeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 133 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 134 Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 135 Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029

Tables

  • Table 1 Global Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 2 Global Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 3 Global Short Bowel Syndrome Market Size, By Region, By Value, 2019-2029
  • Table 4 North America Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 5 North America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 6 North America Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
  • Table 7 United States Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 8 United States Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 9 Canada Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 10 Canada Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 11 Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 12 Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 13 Europe Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
  • Table 14 Germany Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 15 Germany Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 16 United Kingdom Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 17 United Kingdom Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 18 Italy Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 19 Italy Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 20 France Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 21 France Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 22 Spain Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 23 Spain Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 24 Belgium Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 25 Belgium Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 26 Rest of Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 27 Rest of Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 28 The Asia-Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 29 The Asia-Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 30 The Asia-Pacific Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
  • Table 31 China Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 32 China Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 33 India Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 34 India Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 35 Japan Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 36 Japan Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 37 South Korea Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 38 South Korea Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 39 Australia & New Zealand Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 40 Australia & New Zealand Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 41 Indonesia Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 42 Indonesia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 43 Malaysia Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 44 Malaysia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 45 Singapore Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 46 Singapore Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 47 Philippines Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 48 Philippines Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 49 Vietnam Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 50 Vietnam Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 51 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 52 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 53 Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 54 Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 55 Latin America Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
  • Table 56 Brazil Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 57 Brazil Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 58 Mexico Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 59 Mexico Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 60 Argentina Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 61 Argentina Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 62 Peru Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 63 Peru Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 64 Rest of Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 65 Rest of Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 66 The Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 67 The Middle East & Africa Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
  • Table 68 Saudi Arabia Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 69 Saudi Arabia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 70 UAE Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 71 UAE Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 72 Qatar Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 73 Qatar Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 74 Kuwait Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 75 Kuwait Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 76 Iran Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 77 Iran Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 78 South Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 79 South Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 80 Nigeria Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 81 Nigeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 82 Kenya Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 83 Kenya Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 84 Egypt Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 85 Egypt Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 86 Morocco Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 87 Morocco Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 88 Algeria Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 89 Algeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 90 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 91 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 92 Takeda Company Overview
  • Table 93 Takeda Financial Overview
  • Table 94 Emmaus Life Sciences Company Overview
  • Table 95 Emmaus Life Sciences Financial Overview
  • Table 96 Nutricia (Danone) Company Overview
  • Table 97 Nutricia (Danone) Financial Overview
  • Table 98 Merck KGaA Company Overview
  • Table 99 Merck KGaA Financial Overview
  • Table 100 GlyPharma Therapeutics Company Overview
  • Table 101 GlyPharma Therapeutics Financial Overview
  • Table 102 Zealand Pharma Company Overview
  • Table 103 Zealand Pharma Financial Overview
  • Table 104 Sancilio Pharmaceuticals Company Overview
  • Table 105 Sancilio Pharmaceuticals Financial Overview
  • Table 106 Naia Pharmaceuticals Company Overview
  • Table 107 Naia Pharmaceuticals Financial Overview
  • Table 108 Ardelyx Company Overview
  • Table 109 Ardelyx Financial Overview
  • Table 110 Adocia Company Overview
  • Table 111 Adocia Financial Overview
  • Table 112 Aralez Pharmaceuticals Company Overview
  • Table 113 Aralez Pharmaceuticals Financial Overview
  • Table 114 Pivot Pharmaceuticals Company Overview
  • Table 115 Pivot Pharmaceuticals Financial Overview
  • Table 116 Other Prominent Players Company Overview
  • Table 117 Other Prominent Players Financial Overview